Close Menu

While Decode Genetics was able to find many links between genes and disease, "what it didn't find, however, was a business model that made sense," says this Newsweek article, and Decode went bankrupt in November. The company, however, is trying to rise from the ashes with an investment from Saga. The new CEO, Earl Collier is trying to turn Decode into a consulting company that would analyze researchers' sequencing data and "[give] it back in a nicely packaged way."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.